Skip to main content

Table 2 Cardiometabolic complications developed by subjects during the following (divided by BMI and metabolic health). Models were adjusted by sex, BMI, age, smoking, physical activity and family history of T2D and hypertension

From: Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study

Cardiometabolic outcome

Phenotype

Beta

Wald

HR

95CI%

p

Type 2 Diabetes

MHL

MUHL

0.539

2.086

1.715

0.825–3.564

0.149

MHO

−0.188

0.459

0.829

0.481–1.427

0.498

MUHO

0.795

9.044

2.214

1.319–3.716

0.003

Hypertension

MHL

MUHL

0.961

40.583

2.615

1.946–3.515

< 0.001

MHO

0.192

2.277

1.211

0.944–1.554

0.131

MUHO

0.857

47.127

2.355

1.844–3.007

< 0.001